Laplace Interventional Announces $7.9 Million Series A for its Transcatheter Tricuspid Valve

Laplace Interventional Inc. Announces $7.9M Series A for its Transcatheter Tricuspid Valve Technology | Business Wire

Featured Posts

Apexigen Publicly Listed Post-Business Combination

Apexigen Publicly Listed Post-Business Combination

William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022

William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022

2022 SVB Report Results

2022 SVB Report Results

Devoro Medical Reaches Acquisition Agreement with Boston Scientific!

Devoro Medical Reaches Acquisition Agreement with Boston Scientific!

Recent Posts

Search By Tags

Follow Us